As discussed in the previous paragraph, the transcription factor EGR-1 has been shown to associate with the promoter of hPar1 in prostate cancer, leading to hPar1 overexpression and enhancement of invasive properties [9]. The gene discussed is EGR1; the disease is prostate carcinoma.